OAM
Oxford Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,453
| Closed | -$355K | – | 303 |
|
|
2024
Q1 | $355K | Buy |
+8,453
| New | +$355K | 0.37% | 81 |
|
|
2018
Q3 | – | Sell |
-345,067
| Closed | -$173K | – | 1712 |
|
|
2018
Q2 | $173K | Sell |
345,067
-183,807
| -35% | -$92.2K | ﹤0.01% | 1599 |
|
|
2018
Q1 | $1.23M | Buy |
528,874
+85,419
| +19% | +$199K | 0.03% | 835 |
|
|
2017
Q4 | $1.3M | Buy |
443,455
+400,720
| +938% | +$1.17M | 0.03% | 802 |
|
|
2017
Q3 | $122K | Buy |
+42,735
| New | +$122K | ﹤0.01% | 1466 |
|
|
2016
Q4 | – | Sell |
-362,828
| Closed | -$1.47M | – | 778 |
|
|
2016
Q3 | $1.47M | Buy |
+362,828
| New | +$1.47M | 0.05% | 452 |
|
|
2016
Q1 | – | Sell |
-548,708
| Closed | -$8.7M | – | 814 |
|
|
2015
Q4 | $8.7M | Buy |
548,708
+445,200
| +430% | +$7.05M | 0.21% | 90 |
|
|
2015
Q3 | $1.09M | Buy |
+103,508
| New | +$1.09M | 0.03% | 395 |
|
|
2014
Q2 | – | Sell |
-81,223
| Closed | -$1.44M | – | 704 |
|
|
2014
Q1 | $1.44M | Buy |
81,223
+41,227
| +103% | +$728K | 0.04% | 416 |
|
|
2013
Q4 | $968K | Buy |
+39,996
| New | +$968K | 0.02% | 521 |
|
|
2013
Q3 | – | Sell |
-342,739
| Closed | -$5.35M | – | 808 |
|
|
2013
Q2 | $5.35M | Buy |
+342,739
| New | +$5.35M | 0.14% | 223 |
|